Navco Pharmaceuticals Inc.
NAV.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.00 | 1.70K | 600.00 | 2.10K | 4.90K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 200.00 | 1.70K | 600.00 | 2.10K | 4.90K |
|
|
|||||
| Total Current Assets | 200.00 | 1.70K | 600.00 | 2.10K | 4.90K |
| Net Property, Plant & Equipment | -- | -- | -- | 0.00 | 0.00 |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 200.00 | 1.70K | 600.00 | 2.10K | 4.90K |
|
|
|||||
| Total Accounts Payable | 129.80K | 135.60K | 134.90K | 133.40K | 126.30K |
| Total Accrued Expenses | 28.80K | 26.10K | 30.70K | 27.00K | 11.10K |
| Short-term Debt | 77.90K | 76.30K | 62.90K | 61.90K | 63.20K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 443.10K | 452.20K | 459.20K | 452.00K | 461.60K |
| Total Other Current Liabilities | 443.10K | 452.20K | 459.20K | 452.00K | 461.60K |
| Total Current Liabilities | 679.60K | 690.10K | 687.60K | 674.30K | 662.30K |
|
|
|||||
| Total Current Liabilities | 679.60K | 690.10K | 687.60K | 674.30K | 662.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 77.90K | 76.30K | 62.90K | 61.90K | 63.20K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 0.00 |
| Total Liabilities | 679.60K | 690.10K | 687.60K | 674.30K | 662.30K |
|
|
|||||
| Common Stock & APIC | 2.83M | 2.88M | 2.93M | 2.88M | 2.95M |
| Retained Earnings | -3.97M | -4.05M | -4.10M | -4.03M | -4.09M |
| Treasury Stock & Other | 464.80K | 474.30K | 481.60K | 474.10K | 484.20K |
| Total Common Equity | -679.40K | -688.40K | -687.00K | -672.10K | -657.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -679.40K | -688.40K | -687.00K | -672.10K | -657.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -679.40K | -688.40K | -687.00K | -672.10K | -657.40K |
|
|
|||||